Advertisement

European Radiology

, Volume 29, Issue 1, pp 186–194 | Cite as

LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?

  • Seung Soo KimEmail author
  • Jeong Ah Hwang
  • Hyeong Cheol Shin
  • Seo-Youn Choi
  • Tae Wook Kang
  • Sung Shick Jou
  • Woong Hee Lee
  • Suyeon Park
  • Nam Hun Heo
Computed Tomography
  • 240 Downloads

Abstract

Objectives

To compare the sensitivity of Liver Imaging Reporting and Data System (LI-RADS) v2017 for diagnosis of hepatocellular carcinoma (HCC) using multiphasic computed tomography (CT) between patients with and without moderate to severe fatty liver (MSFL).

Methods

This retrospective study included a total of 106 high-risk patients with 112 pathologically proven HCCs who underwent multiphasic CT. Patients were classified as MSFL (24 men, 2 women; mean age, 59.5 years [range, 38–79 years]) and non-MSFL (64 men, 16 women; mean age, 62.9 years [range, 40–89 years]) groups according to unenhanced CT liver and spleen parenchymal attenuation. Two independent radiologists assigned LI-RADS categories and accessed HCC features on CT. Sensitivities for LR-5 assignment and frequencies of HCC features were compared between the two groups.

Results

Sensitivities of LR-5 assignment for diagnosing HCCs were not significantly different between MSFL and non-MSFL groups (65.4% [17/26] vs. 76.7% [66/86] for reviewer 1, p = 0.247; 73.1% [19/26] vs. 76.74% [66/86] for reviewer 2, p = 0.702). No significant differences in the frequencies of arterial hyperenhancement, washout, and capsule were observed between the two groups (96.2% [25/26] vs. 98.8% [85/86], p = 0.412; 80.8% [21/26] vs. 89.5% [77/86], p = 0.308; and 53.8% [14/26] vs. 57% [49/86], p = 0.778, respectively).

Conclusions

LI-RADS v2017 using CT showed comparable sensitivity for diagnosing HCC regardless of MSFL.

Key Points

• Using LI-RADS v2017 with CT, diagnosis of HCC in patients with MSFL showed similar sensitivity to that in patients without MSFL.

• Frequencies of major HCC features (arterial hyperenhancement, washout, and capsule) on CT between the MSFL and non-MSFL groups were not significantly different.

• LI-RADS using CT may be feasible for diagnosing HCC in patients with fatty liver.

Keywords

Carcinoma, hepatocellular Fatty liver Multidetector computed tomography Liver neoplasms 

Abbreviations

CT

Computed tomography

HCC

Hepatocellular carcinoma

HU

Hounsfield units

ICC

Intraclass correlation coefficient

LC

Liver cirrhosis

LI-RADS

Liver Imaging Reporting and Data System

MSFL

Moderate to severe fatty liver

NAFLD

Non-alcoholic fatty liver disease

ROI

Region of interest

TIV

Tumour in vein

Notes

Funding

This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.

This work was supported by the Soonchunhyang University Research Fund.

Compliance with ethical standards

Guarantor

The specific guarantor of this publication is Sung Shick Jou, the head of the Radiology Department of Soonchunhyang University College of Medicine, Cheonan Hospital, Republic of Korea

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

Suyeon Park and Nam Hun Heo kindly provided statistical advice for this manuscript.

Informed consent

Written informed consent was waived by the Institutional Review Board because of the retrospective nature of the study.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

Retrospective, observational, performed at one institution

References

  1. 1.
    Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRefGoogle Scholar
  2. 2.
    Schafer DF, Sorrell MF (1999) Hepatocellular carcinoma. Lancet 353:1253–1257CrossRefGoogle Scholar
  3. 3.
    Younossi ZM, Stepanova M, Afendy M et al (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9:524–530. e521CrossRefGoogle Scholar
  4. 4.
    Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231CrossRefGoogle Scholar
  5. 5.
    Baffy G, Brunt EM, Caldwell SH (2012) Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 56:1384–1391CrossRefGoogle Scholar
  6. 6.
    Boyce CJ, Pickhardt PJ, Kim DH et al (2010) Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 194:623–628CrossRefGoogle Scholar
  7. 7.
    Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022CrossRefGoogle Scholar
  8. 8.
    European Association For The Study Of The Liver (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRefGoogle Scholar
  9. 9.
    Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61:1056–1065CrossRefGoogle Scholar
  10. 10.
    Elsayes KM, Hooker JC, Agrons MM et al (2017) 2017 Version of LI-RADS for CT and MR Imaging: An Update. Radiographics 37:1994–2017CrossRefGoogle Scholar
  11. 11.
    Tang A, Bashir MR, Corwin MT et al (2017) Evidence Supporting LI-RADS Major Features for CT-and MR Imaging–based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. Radiology 286:29–48CrossRefGoogle Scholar
  12. 12.
    Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273:30–50CrossRefGoogle Scholar
  13. 13.
    Yoon JH, Park JW, Lee JM (2016) Noninvasive diagnosis of hepatocellular carcinoma: elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea practice guidelines compared with other guidelines and remaining issues. Korean J Radiol 17:7–24CrossRefGoogle Scholar
  14. 14.
    Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK (2017) Liver imaging reporting and data system v2014 categorisation of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography. J Magn Reson Imaging 45:731–740CrossRefGoogle Scholar
  15. 15.
    Zhang YD, Zhu FP, Xu X et al (2016) Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: Comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models. J Magn Reson Imaging 43:373–383CrossRefGoogle Scholar
  16. 16.
    Ehman EC, Behr SC, Umetsu SE et al (2016) Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (NY) 41:963–969CrossRefGoogle Scholar
  17. 17.
    Corwin MT, Fananapazir G, Jin M, Lamba R, Bashir MR (2016) Differences in liver imaging and reporting data system categorisation between MRI and CT. AJR Am J Roentgenol 206:307–312CrossRefGoogle Scholar
  18. 18.
    Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, Yu ES (2012) Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol 22:1075–1082CrossRefGoogle Scholar
  19. 19.
    Iannaccone R, Piacentini F, Murakami T et al (2007) Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 243:422–430CrossRefGoogle Scholar
  20. 20.
    Fraum TJ, Tsai R, Rohe E et al (2017) Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the liver imaging reporting and data system version 2014. Radiology 286:158–172CrossRefGoogle Scholar
  21. 21.
    Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS (2005) Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 11:281–289CrossRefGoogle Scholar
  22. 22.
    Grazioli L, Olivetti L, Fugazzola C et al (1999) The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol 9:62–67CrossRefGoogle Scholar
  23. 23.
    Bashir MR, Huang R, Mayes N et al (2015) Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. J Magn Reson Imaging 42:305–314CrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2018

Authors and Affiliations

  • Seung Soo Kim
    • 1
    Email author
  • Jeong Ah Hwang
    • 1
  • Hyeong Cheol Shin
    • 1
  • Seo-Youn Choi
    • 2
  • Tae Wook Kang
    • 3
  • Sung Shick Jou
    • 1
  • Woong Hee Lee
    • 1
  • Suyeon Park
    • 4
  • Nam Hun Heo
    • 5
  1. 1.Department of RadiologySoonchunhyang University College of Medicine, Cheonan HospitalCheonan-siRepublic of Korea
  2. 2.Department of RadiologySoonchunhyang University College of Medicine, Bucheon HospitalBucheonRepublic of Korea
  3. 3.Department of Radiology and Center for Imaging ScienceSamsung Medical Center, Sungkyunkwan University School of MedicineSeoulRepublic of Korea
  4. 4.Department of Biomedical StatisticsSoonchunhyang University Seoul HospitalSeoulRepublic of Korea
  5. 5.Clinical Trial Center, Soonchunhyang University Cheonan HospitalCheonan-siRepublic of Korea

Personalised recommendations